Switch to:
More From Other Websites
Sarepta Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 29 2015
Sarepta Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 29 2015
Five things you never knew about Sarepta's interim CEO, Ed Kaye May 29 2015
These dozen Mass. companies are honed in on drugs for rare diseases (BBJ photo gallery) May 28 2015
What You May Have Missed in Biotech: Eye Drug Fails, Ear Drug Flops, and Herpes Drug Succeeds May 23 2015
Biotech stock set to double May 21 2015
Sarepta Therapeutics downgraded by BofA/Merrill May 21 2015
Sarepta’s Feast May Not Satisfy May 20 2015
Stock Pops & Drops: SRPT, PBY, TWTR & FEYE May 20 2015
Analysts See More Upside For Sarepta Therapeutics May 20 2015
6 stocks to watch May 20 2015
BUZZ-Sarepta news lifts other muscular distrophy stocks May 20 2015
Sarepta Explodes On Monster Volume Following Progress With FDA May 20 2015
Sarepta: Is There Upside After 50% Gain? May 20 2015
Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog May 20 2015
Sarepta Soars On New Hope For Muscular-Dystrophy Drug May 20 2015
Sarepta Therapeutics (SRPT) Stock Soars Following Positive Meeting With FDA May 20 2015
How Sarepta Short Interest Is Adding to Its Gains May 20 2015
Jim Cramer -- Regeneron Will Go Higher; Sarepta Is Rallying May 20 2015
Cramer's Mad Dash: Regeneron goes higher May 20 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK